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Abstract 
AIM: To determine whether elevated high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and 
erythrocyte sedimentation rate (ESR), as risk factors of symptomatic lumbar osteoarthritis (OA) in estrogen 
deficiency postmenopausal women. 
METHODS: A case-control study was conducted between January and June 2017. The inclusion criteria include 
post-menopausal women with estrogen deficiency with low back pain. Exclusion criteria were: patients with a 
history of undergoing bilateral oophorectomy, taking hormonal replacement therapy or corticosteroid, 
malignancies, and lumbosacral spine trauma. The blood examinations were taken to measure IL-6 level by 
ELISA, hs-CRP level by spectrophotometry and ESR by modified Westergren method. 
RESULTS: A group of 44 pairs of subjects were divided equally into case and control groups showed that in 
estrogen deficiency postmenopausal women, an increased level of hs-CRP increased the risk for symptomatic 
lumbar OA (OR = 2.83, CI95% = 1.065-8.776, p = 0.034). Also, a high level of IL-6 increased the risk of 
symptomatic lumbar OA (OR = 2.7, CI95% = 0.991-8.320, p = 0.033). No such significant findings were found for 
an increased ESR level.  
CONCLUSION: Elevated level of plasma hs-CRP and IL-6 were concluded as risk factors for symptomatic lumbar 
OA in post-menopausal women. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Low back pain (LBP) is often as a chief 
complaint of the degenerative spine lesion. The 
prevalence of osteoarthritis at the age of 50 years 
both in men and women is relatively similar and 
increasing in women of over 50 years old. Numerous 
causes have been proposed, including estrogen 
alterations that frequently arise in post menopausal 
women in post-menopausal age [1], [2]. 
Lumbar osteoarthritis (OA) is a cartilage 
degeneration involving the narrowing of the 
intervertebral discs, lumbar vertebral osteophyte, and 
osteoarthritis of the facet joints [2], [3], [4]. Some 
suspected causes of lumbar OA include hormonal 
changes in post menopausal women, including 
changes in the hormone estrogen, mechanical stress 
caused by weight gain and ageing process, and 
inflammatory process.  
Chronic inflammation that occurs in lumbar 
OA involved the role of cytokines, like interleukin 6 (IL-
6), IL-10 and IL-1ra [5]. According to another study, 
IL-6 level and IL-6/IL-10 ratio were predictive as the 
risk of lumbar OA [2].
 
An increased level of 
inflammatory mediators will cause a systemic 
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inflammatory reaction. It is now believed that patients 
with LBP have increased levels of hs-CRP and ESR 
[6] [7].
 
C-reactive protein is well established as a 
systemic marker for inflammation and tissue injury [7]. 
Commonly, can be detected within 6-8 hours after the 
injury. Meanwhile, ESR is well-known as a non-
specific marker of inflammation.  
Currently, limited studies have been reported 
regarding hsCRP and ESR levels in LBP patients, 
especially in hormonal-related OA [6] [7] [8] [9]. The 
association between increased hsCRP and low back 
pain is controversial.  
The goal of this study is to elucidate elevated 
hs-CRP, IL-6, and ESR, as risk factors for 
symptomatic lumbar OA in estrogen deficiency 
postmenopausal women. 
 
 
Patients and Methods 
 
This was a case-control study that conducted 
between January and June 2017 at Sanglah Hospital. 
The ethical clearance was certified by the Committee 
of Ethical Research of Udayana University/Sanglah 
Hospital. All patients have signed an informed consent 
paper to be included in this study. 
The total subjects were 88 patients, 
distributed equally into two groups. The case group 
consists of 44 post-menopausal women with 
symptomatic lumbar OA and estrogen deficiency. 
Subjects whose history of bilateral oophorectomy, 
taking hormonal replacement therapy or 
corticosteroid, malignancies, lumbosacral spine 
trauma, or other large joint arthritis, were excluded 
from the study. The control group consists of equally 
44 postmenopausal women, with asymptomatic 
lumbar OA. They were matched individually by body 
mass index (BMI) and age to the case group.  
Plasma IL-6, hs-CRP, and ESR were 
analysed using enzyme-linked immunosorbent assay 
(ELISA), spectrophotometry, and modified Westergren 
method, respectively. The descriptive analysis 
described subjects characteristics. McNemar’s chi-
square was used for bivariate analysis. The odds ratio 
was used for risk estimation. The correlation between 
hs-CRP and IL-6 was analysed using Pearson’s 
Correlation test. 
 
 
Results 
 
The total number of subjects in this study was 
88. They were paired and distributed equally to the 
case and control groups. The median age of the 
subjects was 58 years old. Subject characteristics are 
shown in Table 1. 
We used the cut-off point of IL-6 was 2.264 
pg/L and hs-CRP level of 5.00 mg/L. The odds ratio 
(OR) was 2.7 (95% CI = 0.991-8.320, p = 0.033); 2.83 
(95% CI = 1.065-8.776, p = 0.034) respectively, as 
shown in Table 2.  
Table 1: Subject characteristic of each study group 
Characteristic Case group Control group 
Age (years), median (IQR
1
) 58 (54-61) 58 (53-60) 
Duration of menopause (years), 
median (IQR) 
7 (4-10) 8 (3-10) 
Blood estrogen level (pg/mL), 
median (IQR) 
12.7 (9.00-20.87) 14.16 (9.51-19.23) 
BMI (kg/m
2
), median (IQR)  25.92 (23.27-28.06) 25.28 (22.86-27.37) 
IL-6 (pg/L), mean  SD
2
 
hs-CRP (mg/L), mean  SD 
76.358  152.798 
5.795  4.137 
6.966  12.244 
3.568  3.303 
ESR (mm/hour), mean  SD 13.831  14.798 16.730  12.517 
1
Interquartile range; 
2
Standard deviation. 
 
 
Discussion 
 
Osteoarthritis is a complicated process of joint 
degeneration. Inflammation maybe plays a critical role 
as interleukin upregulation, which arises following the 
ageing of the immune system or obesity [10]. 
Table 2: McNemar’s test for IL-6, hs-CRP, and ESR in 
symptomatic lumbar osteoarthritis 
 
Variables OR
1
 p 95% CI 
IL-6 (pg/L) 
hs-CRP (mg/L) 
2.7 
2.8 
0.033 
0.034 
0.991-8.320 
1.065-8.776 
ESR (mm/hour) 0.5 0.179 0.538-0.181 
1
McNemar’s test, p < 0.05 as significant. 
 
Despite being a degeneration process, 
inflammation also plays a role in OA. The 
inflammatory development that happens in lumbar 
osteoarthritis involves the role of proinflammatory 
cytokines, or anti-inflammatory cytokines [2], [4]. 
In this study, IL-6 was found to be statistically 
significant with (OR = 2.7; p = 0.033). Both Weber et 
al., and Valdes also reported that IL-6 was higher in 
LBP patients [11], [12].
 
Both IL-1 and IL-10 were also 
reported to correlate with the risk of osteoarthritis [11], 
[12]. Chingford reported that circulating IL-6 was 
related to OA development in women.
13
 
Postmenopausal female with knee osteoarthritis also 
showed higher IL-6 levels (p < 0.001) as compared to 
healthy female subjects [14], [17].
 
Ershler et al. also found an increase of IL-6 in 
postmenopausal patients [18], [19].
 
In 
postmenopausal patients, as the estrogen levels 
decline, the osteoclast formation increased and 
leading to bone resorption. The cartilage regulation 
also affected by estrogen levels because the isomer 
of the estrogen receptor (ER-) is expressed in joint 
and growth plate cartilage in humans and other 
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species [1], [20]. 
We also found that hs-CRP levels significantly 
acted as a risk factor (OR = 9.0, p = 0.011) similar to 
reports by Rannou et al., [21].
 
Reports suggested that 
hs-CRP was elevated in the acute phase of 
inflammation [21], [22], [23].
 
Gebhardt found that hs-
CRP level was not associated with either somatic 
function or pain level in LBP patients [24]. 
Both ESR and hs-CRP tests are used to 
detect inflammation. In inflammation, fibrinogen will 
enter the blood and cause raise the ESR [25].
 
The hs-
CRP is synthesised in the liver and is often called an 
acute-phase protein [25]. The elevated hs-CRP level 
is also linked with the manifestation of synovial 
inflammatory infiltrates, and it is also correlated with 
proportions of T-cells in the synovial membrane. 
These findings were independent of the stage of OA 
disease [25].
 
 t mer reporteda correlation between 
pain scale and hs-CRP in patients with acute sciatic 
pain, where a higher hs-CRP level was associated 
with a higher pain level [26]. 
Kim found that IL-6 levels were elevated in 
postmenopausal women who healthy, nonobese, and 
elderly. The IL-6 may be a better marker of constant 
mild inflammatory activity [27]. In this study, as the 
age and BMI were controlled and adjusted, the hs-
CRP and IL-6 level in symptomatic lumbar 
osteoarthritis in postmenopausal women were 
significantly elevated. 
Mild systemic inflammation may have a more 
significant role in symptomatic lumbar OA rather than 
radiographic findings [28]. Symptomatic lumbar OA 
was a degenerative spine disorder in which the 
inflammation also plays a role in the symptom 
manifestation. In this study, the ESR was not 
significant statistically as a risk factor (OR = 0.53, p = 
0.179). This possibly caused by the fact that ESR is 
less specific for inflammation marker compared than 
hs-CRP.  
In conclusion, a high level of plasma IL-6 and 
hs-CRP are risk factors for symptomatic lumbar OA in 
estrogen deficiency postmenopausal women, 
indicating the role of the inflammation process in this 
lumbar OA. 
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